ArticleAnnals of translational medicine2020

Pre-clinical assessment of chimeric antigen receptor t cell therapy targeting CD19+ B cell malignancy.

Sheng-I Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.